Clinical trials
Phase 1 Eye Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Adverum Biotechnologies, Inc. | 1 |
| David M. Brown, M.D. | 1 |
| Genzyme, a Sanofi Company | 1 |
| LENZ Therapeutics, Inc | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Eye Institute (NEI) | 1 |
| Ono Pharma USA Inc | 1 |
| Opthea Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eye Diseases | 15 |
| Macular Degeneration | 7 |
| Retinal Degeneration | 6 |
| Retinal Diseases | 4 |
| Amblyopia | 1 |
| Bites and Stings | 1 |
| Blindness | 1 |
| Choroidal Neovascularization | 1 |
| Diabetic Retinopathy | 1 |
| Geographic Atrophy | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.